HDFCCC Newsletter
Analysis Shows UCSF Cancer Research Ranks Among the World's Most Impactful
From patent filings for new cancer therapies, to articles and book chapters on the latest advances in understanding, diagnosing, and treating cancer, the Helen Diller Family Comprehensive Cancer Center is consistently among the world's top five institutions producing the most impactful and utilized research. [read more]
news UCSF Medical Center Ranks as Best Hospital in California
UCSF was named among the nation's premier medical institutions, ranking as the fifth best hospital in the country and the top-ranked hospital in California, in U.S. News & World Report's 2017-2018 Best Hospitals survey.
news Fate Of San Francisco's Ban On Flavored Tobacco Products Is Now Up To Voters
Financed by the tobacco industry, a coalition of local business owners has blocked San Francisco's new ban on flavored tobacco products until voters decide whether to uphold or overturn it.
  The UCSF Resource Allocation Program (RAP) offers many cancer-related funding opportunities! Apply from Aug 21 - Sept 18. View the full list of RAP grants.

> cancer-related funding
> limited submissions

Welcome New Members
Stephen Floor, PhD - Associate Member, Pediatric Malignancies, Neurologic Oncology
Miller Huang, PhD - Associate Member, Pediatric Malignancies
Christina Yau, PhD - Associate Member, Breast Oncology
Valerie Yerger, MA, ND - Associate Member, Tobacco Control
Awards & Distinctions
Bin Chen, PhD received a grant of $569,000 from the National Center for Advancing Translational Sciences (NCATS) for his project, "Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma."
Pamela Munster, MD received an NCI grant of $363,000 for her project, "Developing silastic-silicone for the local delivery of hormonal therapy to prevent and treat breast cancer."
Kevin Shannon, MD and William Weiss MD, PhD each received research grants from St. Baldrick's Foundation. Learn more about Dr. Shannon's project and Dr. Weiss's project.
Jeremy Reiter, MD, PhD and David Raleigh, MD, PhD received a QBI Bold & Basic grant for their project, "How fats cause cancer: Lipids in the primary cilium activate oncogenic Hedgehog signaling."
Bjoern Schwer, MD, PhD and Kira Poskanzer, PhD received a QBI Bold & Basic grant for their project, "A brain organogenesis platform for primate neurobiology and brain tumor research."
William Weiss, MD, PhD and Kevan Shokat, PhD received a QBI Bold & Basic grant for their project, "Trapping MYC in cancer."
Catherine Park, MD was elected to the American Society for Radiation Oncology's board of directors. She will serve as science council vice chair. Read more.
Lan Wang, PhD and Xin Zhou, PhD each received fellowship awards from the Damon Runyon Cancer Research Foundation.
Jennifer Puck, MD received the Boyle Scientific Achievement Award from the Immune Deficiency Foundation.
Arthur Weiss, MD, PhD and Jonathan Weissman, PhD were elected as associate members to the European Molecular Biology Organization.
Francis Yao, MD is among this year's UCSF Department of Medicine Master Clinicians.
Keith Yamamoto, PhD was appointed vice chair of the National Academy of Medicine Council.
In the News
news Genome sequencing method can detect clinically relevant mutations using 5 CTCs
Science Daily | August 15, 2017
news Important to Communicate Cancer Prevention to Young Adults to Reduce Risks Later in Life
Medical Xpress | August 14, 2017
news Genomic Landscape of Prostate Cancer Aligns With Breast Cancer Subtypes
OncLive | August 4, 2017
news Zuckerberg, Chan give UCSF $10 million for health data research
SF Chronicle | July 28, 2017
news FDA Clears Wider Use of Cooling Cap to Reduce Hair Loss during Chemotherapy
NCI | July 21, 2017
news Immune-Cell Numbers Predict Response to Combination Immunotherapy in Melanoma
UCSF | July 20, 2017
Recent Publications

Dhawan MS, Bartelink IH, Aggarwal R, Leng J, Zhang JZ, Pawlowska N, Terranova-Barberio M, Grabowsky JA, Gewitz A, Chien AJ, Moasser MM, Kelley RK, Maktabi T, Thomas S, Munster PN. Differential toxicity in patients with and without DNA repair mutations: Phase I Study of Carboplatin and Talazoparib in advanced solid tumors. Clin Cancer Res. 2017 Aug 8.

van 't Veer LJ, Yau C, Yu NY, Benz CC, Nordenskjold B, Fornander T, Stal O, Esserman LJ, Lindstrom LS. Tamoxifen therapy benefit for patients with 70-gene signature high and low risk. Breast Cancer Res Treat. 2017 Aug 4.

Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. MicroRNA-720 regulates E-cadherin-αE-catenin complex and promotes renal cell carcinoma. Mol Cancer Ther. 2017 Aug 11.

Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JWT, Tice JA, Ziv E, Kerlikowske K, Cummings SR. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast Cancer Res Treat. 2017 Aug 8.

Sept 8: Friday Cancer Center Seminar Series - UCSF Mission Bay
Collin Blakely, MD, PhD, UCSF
Sept 16: 5th Annual Gynecologic Cancer Symposium - UCSF Mission Bay
Patients and community members will learn about the latest developments in diagnosis, treatment, and quality of life.
Sept 16: OncLive State of the Science Summit - InterContinental San Francisco
This meeting offers community oncologists education on the science driving new thinking in GU cancer management and the associated clinical benefits for patients.
Sept 20: Breast Oncology Program Seminar Series - UCSF Mount Zion
Michael Press, MD, PhD, Keck School of Medicine, USC
Employment and Training
NCI Cancer Prevention Fellowship Program
NCI Clinical Investigator Development Program
Molecular/Cell Biologist (Adjunct Faculty), UCSF Institute for Neurodegenerative Diseases
Scientist/Sr. Scientist, Antibody Drug Conjugation Chemistry and Biology, Seattle Genetics
Operations Manager, UCSF Center for Tobacco Control Research and Education
Assistant Professor of Health Sciences (2 positions), California State University-East Bay
Postdoctoral positions in the UCSF Institute for Human Genetics
View opportunities from QB3 startups
  UNSUBSCRIBE | ABOUT | CONTACT facebook twitter